Ordering
Available Variants10 mg
CHA.52845-10mg
Price
€269.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.52845-10mg | €269.60 |
phyproof® Reference Substance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C21H22O7 |
|---|---|
| CAS Number | 73069-27-9 |
| Molecular Weight | 386.40 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| MDL number | MFCD31561439 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
(+)-Praeruptorin A, with a CAS number of 73069-27-9, is a naturally occurring compound isolated from the roots of the Peucedanum praeruptorum plant. This compound has been found to exhibit various pharmacological activities, including anti-inflammatory and cardiovascular protective effects. Studies have shown that (+)-Praeruptorin A can inhibit the production of pro-inflammatory cytokines and enzymes, thereby reducing inflammation and oxidative stress. Additionally, it has been reported to have a positive impact on cardiovascular health by improving blood lipid profiles and preventing platelet aggregation. The compounds unique structure and bioactive properties make it a promising candidate for further research and potential therapeutic applications, particularly in the development of novel treatments for inflammatory and cardiovascular diseases. Further investigation is needed to fully elucidate the mechanisms of action and potential benefits of (+)-Praeruptorin A.
